Look out Dupixent, Lilly’s lebrikizumab is on the marchEli Lilly had a lot riding on its two phase 3 trials of IL-13 inhibitor lebrikizumab in atopic Share XLook out Dupixent, Lilly’s lebrikizumab is on the marchhttps://pharmaphorum.com/news/look-out-dupixent-lillys-lebrikizumab-is-on-the-march/
